SCHEMBL5016247

SCHEMBL5016247

COc1cc(OC)c(CC2CCN(c3ccc4c(O)ccnc4c3)CC2)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.43
HTR7 P34969 7/20 0.42
PDE10A Q9Y233 6/20 0.42
ADRA1D P25100 2/20 0.42
ADRA1A P35348 2/20 0.42
ADRA1B P35368 2/20 0.42
PRKDC P78527 3/20 0.41
GAA P10253 1/20 0.40
HRH4 Q9H3N8 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
KDM4E B2RXH2 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5016244 0.88 HTR1A (0.42) HTR1AHTR7PDE10AADRA1DADRA1A
SCHEMBL27666237 0.81 HTR1A (0.39) HTR1AHTR7PDE10AADRA1DADRA1A
SCHEMBL2093006 0.76 PRKDC (0.51) HTR1AHTR7PDE10AADRA1DADRA1A
SCHEMBL2089310 0.71 PDE3B (0.53) PDE10APDE3BPDE3A
SCHEMBL2090190 0.70 CHRM4 (0.37) HTR1APDE10APRKDCGAACDK1
SCHEMBL2093999 0.69 ADORA2A (0.35) HTR1AHTR7PDE10AHRH4HRH3
SCHEMBL14608987 0.69 HTR1A (0.40) HTR1AHRH4HRH3
SCHEMBL8600213 0.69 MAPT (0.54) GAAKDM4EALDH1A1MAPTL3MBTL1
SCHEMBL2092255 0.68 TP53 (0.42) HTR1APRKDCCDK1
SCHEMBL8601147 0.68 PRKDC (0.56) PRKDCMAPTCDK1ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 EP disclosed
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed